SCHEMBL5773610

SCHEMBL5773610

CNCc1csc(C=NNc2ccc(-c3cn4cc(I)ccc4n3)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.43
CDK4 P11802 2/20 0.37
CCND1 P24385 2/20 0.37
CCNE1 P24864 2/20 0.37
CDK2 P24941 2/20 0.37
NPC1 O15118 7/20 0.34
RAB9A P51151 7/20 0.34
KDM4E B2RXH2 6/20 0.34
ALDH1A1 P00352 6/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
HPGD P15428 3/20 0.34
KMT2A Q03164 2/20 0.34
PAX8 Q06710 2/20 0.34
MEN1 O00255 1/20 0.34
MITF O75030 1/20 0.34
KDM5A P29375 1/20 0.34
KDM5C P41229 1/20 0.34
TP53 P04637 1/20 0.33
POLB P06746 2/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775791 0.84 APP (0.42) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL5775787 0.84 APP (0.42) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL5775797 0.83 ALDH1A1 (0.38) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL5780438 0.81 APP (0.43) APPCDK4CCND1CCNE1CDK2
SCHEMBL5778184 0.81 APP (0.46) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL5778186 0.81 APP (0.46) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL5775433 0.74 RAB9A (0.49) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL13045468 0.71 APP (0.66) APPNPC1RAB9AKDM4EALDH1A1
SCHEMBL5775263 0.71 CDK4 (0.40) CDK4CCND1CCNE1CDK2NPC1
SCHEMBL5776536 0.71 POLB (0.45) APPNPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276433-A1 Hydrazone derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1612204-A1 HYDRAZONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276433-A1 Hydrazone derivative APP, PRNP, HTT APP 1/4885CDK4 2878/4885CCND1 1402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.